IGF-1 LR3 vs HGH 191AA: Comparing Growth Factor Research Peptides

IGF-1 LR3 and HGH 191AA are frequently studied together because they sit on the same endocrine axis, but they are not interchangeable research tools. Understanding where each acts is essential to designing a protocol that isolates the variable a researcher actually wants to measure.

Where Each Compound Acts

HGH 191AA is the upstream hormone — it triggers hepatic and local IGF-1 production as one of several downstream effects, alongside direct lipolytic and counter-regulatory glucose signalling. IGF-1 LR3 is a long-acting analog of the downstream growth factor itself, engineered with an amino acid substitution and extended N-terminal sequence (the "LR3" modification) that dramatically reduces binding to IGF-binding proteins, extending its research half-life well beyond native IGF-1.

This structural difference means:

• ·HGH 191AA produces broad, systemic effects across multiple tissue types and metabolic pathways, with IGF-1 elevation being just one downstream consequence
• ·IGF-1 LR3 produces more targeted anabolic signalling at the tissue level, with reduced systemic metabolic disruption since it bypasses upstream pituitary and hepatic regulation

Mechanism Comparison

| Variable | IGF-1 LR3 | HGH 191AA |

|---|---|---|

| Point of action | Downstream growth factor | Upstream pituitary hormone |

| Primary receptor | IGF-1 receptor | GH receptor |

| Metabolic (glucose) effect | Minimal direct effect | Counter-regulatory (insulin-antagonistic) |

| Research half-life | Extended via LR3 modification | Short, requires frequent dosing |

| Typical research focus | Localized anabolic / hypertrophy signalling | Systemic body composition, recovery, aging models |

Research Applications

IGF-1 LR3 research has concentrated on:

• ·Muscle hyperplasia and satellite cell activation studies
• ·Localized tissue growth signalling distinct from systemic hormone elevation
• ·Research protocols requiring anabolic signalling without the glucose-regulatory confound introduced by GH

HGH 191AA research, by contrast, is more often paired with body composition and recovery studies — see the full HGH 191AA research overview — precisely because its systemic action profile is the variable being measured.

Combined Research Designs

Because IGF-1 LR3 sits downstream of HGH 191AA on the same axis, some comparative protocols use both compounds to separate "hormone-driven IGF-1 elevation" from "direct IGF-1 receptor engagement" as independent variables — a design question worth planning carefully before ordering reagents.

Storage Note

Both compounds are lyophilized and moisture-sensitive. IGF-1 LR3 in particular is prone to degradation once reconstituted and should be used within a shorter window than most peptides — consult the peptide storage guide for compound-specific stability tables.

Shop IGF-1 LR3 or HGH 191AA.

Note: IGF-1 LR3 and HGH 191AA are sold by JA Performance strictly for laboratory and in vitro research use. Not for human consumption.